Recent data from the Centers for Disease Control and Prevention (CDC) reveals declining vaccination rates among U.S. Children born in 2021 and 2022 for several key vaccines, including influenza, hepatitis B, rotavirus, pneumococcal, and Haemophilus influenzae type b (Hib). These decreases, coupled with persistent disparities in access, raise concerns about potential outbreaks and a weakening of community immunity.
The erosion of childhood vaccination coverage isn’t merely a statistical blip; it represents a tangible threat to public health, potentially reversing decades of progress in controlling preventable infectious diseases. The observed declines are particularly worrying given the recent resurgence of diseases like measles, highlighting the critical importance of maintaining high vaccination rates to protect vulnerable populations. This isn’t simply about individual risk; it’s about the collective immunity – or herd immunity – that safeguards everyone, including those too young to be vaccinated or those with compromised immune systems.
In Plain English: The Clinical Takeaway
- Vaccination rates are down: Fewer children are getting important shots like the flu vaccine and the first dose of the hepatitis B vaccine.
- Unequal access is a problem: Children from lower-income families and certain racial groups are less likely to be fully vaccinated.
- This increases risk: Lower vaccination rates mean a higher chance of outbreaks of diseases like measles and whooping cough.
The Declining Trend: A Closer Look at the Data
The CDC’s analysis, based on data from 27,392 children, demonstrates a concerning trend. Influenza vaccination coverage with at least two doses before 24 months of age fell to 53.5% in the 2021-2022 birth cohort, down from 61.0% in 2019-2020. The hepatitis B birth dose, a crucial preventative measure against perinatal transmission of the virus, decreased from 81.1% to 79.3%, continuing a three-year decline. The mechanism of action for the hepatitis B vaccine relies on stimulating the body’s immune system to produce antibodies against the hepatitis B surface antigen (HBsAg), providing protection against infection. Without this initial protection, approximately 90% of infants born to HBsAg-positive mothers are at risk of developing chronic hepatitis B infection, with a 25% lifetime risk of liver failure or hepatocellular carcinoma. Hib vaccination rates similarly saw a slight decrease, from 92.9% to 91.9%. A recent cluster of Hib cases, including one fatality, in Florida underscores the potential consequences of reduced coverage. Rotavirus and pneumococcal vaccination rates also experienced modest declines, falling from 75.8% to 74.2% and 4-dose completion rates decreasing by 1.5% respectively.
Regional Disparities and Socioeconomic Factors
The CDC report highlights significant geographic variations in vaccination coverage. Influenza vaccination rates, for example, ranged from a low of 25.2% in Mississippi to a high of 78.3% in Massachusetts during the 2021-2022 period. This disparity is likely multifactorial, influenced by differences in state-level vaccination policies, healthcare access, and public health infrastructure. The report confirms persistent inequalities based on socioeconomic status and race/ethnicity. Children eligible for the Vaccines for Children (VFC) program – a federal initiative providing free vaccines to uninsured or underinsured children – consistently exhibited lower vaccination rates across all vaccine types compared to their eligible peers. Black non-Hispanic children had lower vaccination coverage than White non-Hispanic children. These disparities are often linked to factors such as limited access to healthcare, transportation barriers, language barriers, and vaccine hesitancy rooted in historical mistrust of the medical system.
The Resurgence of Measles and the Importance of Herd Immunity
Despite overall declines in some areas, coverage for measles, mumps, and rubella (MMR) remains above 90% for at least one dose. However, Here’s still below the 95% threshold required for achieving herd immunity – the level of protection needed to prevent widespread outbreaks. In 2024, the U.S. Experienced its highest number of measles cases since 2000, with 2,285 cases reported, 93% of which occurred in unvaccinated or individuals with unknown vaccination status. Measles is highly contagious, with a basic reproduction number (R0) of 12-18, meaning that each infected person can spread the disease to 12-18 susceptible individuals. This high transmissibility underscores the critical importance of maintaining high vaccination rates to prevent outbreaks. The MMR vaccine works by inducing an immune response to the measles, mumps, and rubella viruses, creating long-lasting immunity.
| Vaccine | Coverage (2019-2020 Cohort) | Coverage (2021-2022 Cohort) | Change |
|---|---|---|---|
| Influenza (≥2 doses) | 61.0% | 53.5% | -7.5% |
| Hepatitis B (Birth Dose) | 81.1% | 79.3% | -1.8% |
| Hib (≥3 doses) | 92.9% | 91.9% | -1.0% |
| Rotavirus (Complete Series) | 75.8% | 74.2% | -1.6% |
| Pneumococcal (≥4 doses) | N/A | N/A | -1.5% |
Funding and Research Transparency
The data presented in the CDC’s Morbidity and Mortality Weekly Report (MMWR) is derived from the National Immunization Survey-Childhood (NIS-Child), a nationally representative survey funded by the CDC. The NIS-Child collects data on vaccination coverage, vaccine-preventable diseases, and parental attitudes towards vaccination. While the CDC is a public health agency, it’s important to acknowledge that its research is subject to political and budgetary constraints. Independent research funded by organizations like the Bill & Melinda Gates Foundation also contributes significantly to the understanding of vaccine effectiveness and coverage.
“We are deeply concerned by the declining vaccination rates we’re seeing across several key childhood vaccines. These declines put our children and communities at risk of preventable diseases, and we must function together to address the factors contributing to this trend.” – Dr. José Romero, Director of the CDC’s Immunization Services Division (CIDRAP, March 2026).
Contraindications & When to Consult a Doctor
While vaccines are generally safe and effective, certain medical conditions may warrant caution or contraindication. Individuals with a history of severe allergic reaction (anaphylaxis) to a vaccine component should not receive that vaccine. Children with weakened immune systems due to conditions like leukemia or HIV/AIDS may require modified vaccination schedules or alternative vaccine formulations. Parents should always consult with their pediatrician to discuss any concerns about vaccination and to determine the appropriate vaccination schedule for their child. If a child experiences symptoms such as high fever, seizures, or severe allergic reaction following vaccination, seek immediate medical attention.
The current decline in childhood vaccination rates is a complex issue with far-reaching implications. Addressing this challenge requires a multifaceted approach, including strengthening public health infrastructure, improving access to healthcare, combating vaccine misinformation, and fostering trust in the medical community. Continued monitoring of vaccination coverage rates and targeted interventions to address disparities are essential to protect the health of future generations.
References
- Centers for Disease Control and Prevention. (2024). Vaccination Coverage Among Children Aged 19–35 Months — United States, 2022. Morbidity and Mortality Weekly Report (MMWR), 75(11), 313–321. https://www.cdc.gov/mmwr/volumes/75/wr/mm7511a2.htm?s_cid=OS_mm7511a2_w
- CIDRAP. (2026). Youngest US kids’ uptake drops for flu, hepatitis B, 3 other vaccines. https://www.cidrap.umn.edu/childhood-vaccines/youngest-us-kids-uptake-drops-flu-hepatitis-b-3-other-vaccines
- Plotkin, S. A., Orenstein, W. A., & Offit, P. A. (2018). Plotkin’s Vaccines (6th ed.). Elsevier.
- World Health Organization. (2023). Measles. https://www.who.int/news-room/fact-sheets/detail/measles
- Omer, S. B., Saad-Din, T., Deeks, D., & GlaxoSmithKline. (2016). Vaccine hesitancy: understanding the complex reasons why people delay or refuse vaccination. Human vaccines & immunotherapeutics, 12(8), 1955–1961. https://doi.org/10.1089/hum.2016.134
